ATMP vs. MRK

Last updated Jun 14, 2026

ATMP (Barclays ETN+ Select MLP ETN) is MLPs fund tracking the CIBC Atlas Select MLP VWAP, while MRK (Merck & Co., Inc.) is a stock. Over the past 10 years, ATMP returned 5.20%/yr vs 11.59%/yr for MRK. At a 0.20 correlation, their price movements are largely independent.

Performance

ATMP vs. MRK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Barclays ETN+ Select MLP ETN (ATMP) and Merck & Co., Inc. (MRK). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ATMP achieves a 20.60% return, which is significantly higher than MRK's 13.94% return. Over the past 10 years, ATMP has underperformed MRK with an annualized return of 5.20%, while MRK has yielded a comparatively higher 11.59% annualized return.

ATMP

• 1D: 0.46%
• 1M: -3.30%
• YTD: 20.60%
• 6M: 20.43%
• 1Y: 18.09%
• 3Y*: 21.55%
• 5Y*: 15.05%
• 10Y*: 5.20%

MRK

• 1D: -1.42%
• 1M: 4.97%
• YTD: 13.94%
• 6M: 20.60%
• 1Y: 50.99%
• 3Y*: 5.87%
• 5Y*: 12.81%
• 10Y*: 11.59%

*Multi-year figures are annualized to reflect compound growth (CAGR)

ATMP vs. MRK - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ATMP Barclays ETN+ Select MLP ETN	20.60%	1.73%	31.66%	14.51%	20.71%	33.06%	-34.39%	0.39%	-14.55%	-11.89%
MRK Merck & Co., Inc.	13.94%	9.79%	-6.26%	1.01%	49.42%	1.75%	-7.20%	22.27%	39.95%	-1.49%

Correlation

The correlation between ATMP and MRK is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.06
Correlation (3Y) Calculated over the trailing 3-year period	0.10
Correlation (5Y) Calculated over the trailing 5-year period	0.14
Correlation (10Y) Calculated over the trailing 10-year period	0.19
Correlation (All Time) Calculated using the full available price history since Mar 13, 2013	0.20

The correlation between ATMP and MRK shifts across timeframes, from 0.06 (1 year) to 0.20 (all time), reflecting how their relationship changes across market environments.

Return for Risk

ATMP vs. MRK — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ATMP

ATMP Risk / Return Rank: 44
ATMP Sharpe Ratio Rank: 42
ATMP Sortino Ratio Rank: 41
ATMP Omega Ratio Rank: 38
ATMP Calmar Ratio Rank: 58
ATMP Martin Ratio Rank: 41

MRK

MRK Risk / Return Rank: 88
MRK Sharpe Ratio Rank: 88
MRK Sortino Ratio Rank: 88
MRK Omega Ratio Rank: 85
MRK Calmar Ratio Rank: 91
MRK Martin Ratio Rank: 90

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ATMP vs. MRK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Barclays ETN+ Select MLP ETN (ATMP) and Merck & Co., Inc. (MRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ATMP	MRK	Difference
Sharpe ratio: Return per unit of total volatility	1.31	1.88	-0.58
Sortino ratio: Return per unit of downside risk	1.87	2.80	-0.93
Omega ratio: Gain probability vs. loss probability	1.23	1.33	-0.11
Calmar ratio: Return relative to maximum drawdown	2.53	4.49	-1.96
Martin ratio: Return relative to average drawdown	5.89	11.22	-5.33

ATMP vs. MRK - Sharpe Ratio Comparison

The current ATMP Sharpe Ratio is 1.31, which is lower than the MRK Sharpe Ratio of 1.88. The chart below compares the historical Sharpe Ratios of ATMP and MRK, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

ATMP vs. MRK - Drawdown Comparison

The maximum ATMP drawdown since its inception was -80.86%, which is greater than MRK's maximum drawdown of -68.61%. Use the drawdown chart below to compare losses from any high point for ATMP and MRK.

Drawdown Indicators

	ATMP	MRK	Difference
Max Drawdown Largest peak-to-trough decline	-80.86%	-68.61%	-12.25%
Max Drawdown (1Y) Largest decline over 1 year	-7.30%	-11.37%	+4.07%
Max Drawdown (3Y) Largest decline over 3 years	-16.48%	-43.44%	+26.96%
Max Drawdown (5Y) Largest decline over 5 years	-22.98%	-43.44%	+20.46%
Max Drawdown (10Y) Largest decline over 10 years	-75.66%	-43.44%	-32.22%
Current Drawdown Current decline from peak	-5.61%	-5.03%	-0.58%
Average Drawdown Average peak-to-trough decline	-31.08%	-18.83%	-12.25%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.13%	4.54%	-1.41%

Volatility

ATMP vs. MRK - Volatility Comparison

The current volatility for Barclays ETN+ Select MLP ETN (ATMP) is 5.64%, while Merck & Co., Inc. (MRK) has a volatility of 9.57%. This indicates that ATMP experiences smaller price fluctuations and is considered to be less risky than MRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ATMP	MRK	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.64%	9.57%	-3.93%
Volatility (6M) Calculated over the trailing 6-month period	10.99%	18.04%	-7.05%
Volatility (1Y) Calculated over the trailing 1-year period	14.18%	27.18%	-13.00%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	22.25%	23.66%	-1.41%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	27.67%	22.96%	+4.71%

Dividends

ATMP vs. MRK - Dividend Comparison

ATMP has not paid dividends to shareholders, while MRK's dividend yield for the trailing twelve months is around 2.79%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ATMP Barclays ETN+ Select MLP ETN	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
MRK Merck & Co., Inc.	2.79%	3.12%	3.14%	2.72%	2.52%	3.41%	3.03%	2.48%	2.60%	3.36%	3.14%	3.43%

Frequently Asked Questions

Can I hold both ATMP and MRK in my portfolio?

ATMP and MRK have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ATMP or MRK?

MRK has higher volatility (9.57%) compared to ATMP (5.64%). In terms of maximum drawdown, ATMP dropped -80.86% vs MRK's -68.61%.

Which has better risk-adjusted returns?

MRK currently has the higher Sharpe Ratio (1.88 vs 1.30), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.